
Jurkat lysates probed with IL24 Polyclonal Antibody, Unconjugated (bs-7537R) at 1:300 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:10000 for 60 min at 37˚C.
IL24 Polyclonal Antibody
BS-10576R

ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetIL24
Overview
- SupplierBioss Antibodies
- Product NameIL24 Polyclonal Antibody
- Delivery Days Customer16
- ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
- Applications SupplierWB(1:300-5000), ELISA(1:500-1000), IHC-P(1:200-400), IHC-F(1:100-500), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 ug/ul
- ConjugateUnconjugated
- Gene ID11009
- Target nameIL24
- Target descriptioninterleukin 24
- Target synonymsC49A; FISP; IL10B; IL-4-induced secreted protein; interleukin-24; MDA7; melanocyte-associated Mda-7; melanoma differentiation-associated gene 7 protein; MOB5; ST16; suppression of tumorigenicity 16 (melanoma differentiation)
- HostRabbit
- IsotypeIgG
- Protein IDQ13007
- Protein NameInterleukin-24
- Storage Instruction-20°C
- UNSPSC12352203
References
- Combination therapy with F5/35 fiber chimeric conditionally replicative adenoviruses expressing IL-24 enhances the antitumor effect of temozolomide against melanoma. Yang M et al., 2018 Dec, Cancer MedRead more
- A conditionally replicating adenovirus expressing IL-24 acts synergistically with temozolomide to enhance apoptosis in melanoma cells in vitro. Liang Z et al., 2017 Jun, Oncol LettRead more